Analysts at Aegis Capital initiated coverage of Inovio Pharmaceuticals IncINO with a Buy rating. The price target for Inovio Pharmaceuticals is set to $12. Inovio Pharmaceuticals shares closed at $6.34 on Friday.
Analysts at H.C. Wainwright initiated coverage on Steadymed LtdSTDY with a Buy rating. The price target for Steadymed is set to $10. Steadymed shares closed at $3.90 on Friday.